US 9126994
Crystalline form of a quinolinone-carboxamide compound
granted A61KA61K31/46A61P
Quick answer
US patent 9126994 (Crystalline form of a quinolinone-carboxamide compound) held by Theravance Biopharma R&D IP, LLC expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Sep 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/46, A61P, A61P1/00, A61P1/04